C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation

被引:118
作者
Park, Duk-Woo
Yun, Sung-Cheol [2 ]
Lee, Jong-Young
Kim, Won-Jang
Kang, Soo-Jin
Lee, Seung-Whan
Kim, Young-Hak
Lee, Cheol Whan
Kim, Jae-Joong
Park, Seong-Wook
Park, Seung-Jung [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Ctr Med Res & Informat, Div Biostat, Seoul 138736, South Korea
关键词
C-reactive protein; stents; thrombosis; CORONARY-ARTERY-DISEASE; CLINICAL-OUTCOMES; PROGNOSTIC VALUE; INFLAMMATION; REVASCULARIZATION; ANGIOPLASTY; RESTENOSIS; MORTALITY; FREQUENCY; MARKERS;
D O I
10.1161/CIRCULATIONAHA.109.876763
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Although C-reactive protein (CRP) has been proposed as a useful biomarker for predicting atherothrombosis, the association between CRP and stent thrombosis after drug-eluting stent implantation has not been defined. Methods and Results-We prospectively evaluated 2691 patients treated with drug-eluting stents who had a baseline CRP measurement. The primary outcome was stent thrombosis; secondary outcomes were death, myocardial infarction (MI), death or MI, and target vessel revascularization. During follow-up (median, 3.9 years), 32 patients had definite or probable stent thrombosis, 137 patients died, 227 had an MI, and 195 underwent target vessel revascularization. In multivariable Cox proportional-hazards models, elevated levels of CRP were significantly associated with increased risk of stent thrombosis (hazard ratio, 3.86; 95% confidence interval, 1.82 to 8.18; P < 0.001). Elevated CRP levels also significantly predicted the risks of death (hazard ratio, 1.61; 95% confidence interval, 1.13 to 2.28; P = 0.008), MI (hazard ratio, 1.63; 95% confidence interval, 1.25 to 2.12; P = 0.001), and death or MI (hazard ratio, 1.61; 95% confidence interval, 1.29 to 2.00; P < 0.001) but not target vessel revascularization (hazard ratio, 1.20; 95% confidence interval, 0.90 to 1.61; P = 0.21). The incorporation of CRP into a model with patient, lesion, and procedural factors resulted in a significant increase in the C statistic for the prediction of stent thrombosis, MI, and the composite of death or MI. Conclusions-Elevated CRP levels were significantly associated with increased risks of stent thrombosis, death, and MI in patients receiving drug-eluting stents, suggesting the usefulness of inflammatory risk assessment with CRP. Given the relatively infrequent occurrence of stent thrombosis, death, and MI, larger studies with longer-term follow-up are required to confirm the novel relationship. (Circulation. 2009; 120: 1987-1995.)
引用
收藏
页码:1987 / U29
页数:12
相关论文
共 36 条
[1]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[2]  
[Anonymous], 1994, An introduction to the bootstrap: CRC press
[3]   Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials [J].
Bavry, Anthony A. ;
Kumbhani, Dharam J. ;
Helton, Thomas J. ;
Borek, Przemyslaw P. ;
Mood, Girish R. ;
Bhatt, Deepak L. .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (12) :1056-1061
[4]   Activation of inflammation and coagulation after infusion of C-reactive protein in humans [J].
Bisoendial, RJ ;
Kastelein, JJP ;
Levels, JHM ;
Zwaginga, JJ ;
van den Bogaard, B ;
Reitsma, PH ;
Meijers, JCM ;
Hartman, D ;
Levi, M ;
Stroes, ESG .
CIRCULATION RESEARCH, 2005, 96 (07) :714-716
[5]   Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention [J].
Chew, DP ;
Bhatt, DL ;
Robbins, MA ;
Penn, MS ;
Schneider, JP ;
Lauer, MS ;
Topol, EJ ;
Ellis, SG .
CIRCULATION, 2001, 104 (09) :992-997
[6]   Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study [J].
Daemen, Joost ;
Wenaweser, Peter ;
Tsuchida, Keiichi ;
Abrecht, Linda ;
Sophia, Vaina ;
Morger, Cyrill ;
Kukreja, Neville ;
Jueni, Peter ;
Sianos, Georgios ;
Hellige, Gerrit ;
van Domburg, Ron T. ;
Hess, Otto M. ;
Boersma, Eric ;
Meier, Bernhard ;
Windecker, Stephan ;
Serruys, Patrick W. .
LANCET, 2007, 369 (9562) :667-678
[7]   Increased thrombosis after arterial injury in human C-reactive protein - Transgenic mice [J].
Danenberg, HD ;
Szalai, AJ ;
Swaminathan, RV ;
Peng, L ;
Chen, ZP ;
Seifert, P ;
Fay, WP ;
Simon, DI ;
Edelman, ER .
CIRCULATION, 2003, 108 (05) :512-515
[8]   C-reactive protein and coronary events following percutaneous coronary angioplasty [J].
de Winter, RJ ;
Koch, KT ;
van Straalen, JP ;
Heyde, G ;
Bax, M ;
Schotborgh, CE ;
Mulder, KJ ;
Sanders, GT ;
Fischer, J ;
Tijssen, JGP ;
Piek, JJ .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (02) :85-90
[9]   Assessment of hemostatic risk factors in predicting arterial thrombotic events [J].
Feinbloom, D ;
Bauer, KA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2043-2053
[10]   C-reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents [J].
Gaspardone, A ;
Versaci, F ;
Tomai, F ;
Citone, C ;
Proietti, I ;
Gioffrè, G ;
Skossyreva, O .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (09) :1311-1316